Oncolytics Biotech Inc.’s ONCY share price has dipped by 5.04%, which has investors questioning if this is right time to buy.

Intensity Therapeutics Inc., a Shelton-based biotechnology company focused on developing cancer therapies, on Friday said it ...

Days after the Women’s Health Initiative, one of the largest and longest women’s health studies in the world, announced that ...

Erasca continues developing novel RAS-pathway cancer drugs, backed by funding through 2027 and promising early results. Find ...

European equities traded in the US as American depositary receipts were lower Friday morning, down 0.21% to 1,378.56 on the S&P Europe Select ADR Index. It is up 3.5% for the week. From continental ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid to focus resources on a pair of cancer cell therapies.

The hold, placed by the FDA on an early-stage clinical trial of an experimental BET inhibitor, stems from a recent ...

Cancer completely disappeared from two-thirds of 24 patients treated with a combination of the antibody petosemtamab and ...

Vyne Therapeutics’ attempt to develop a safer, more tolerable BET inhibitor has hit turbulence. | Vyne Therapeutics’ attempt ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

Scientists have launched a miniature lab into Earth's orbit, which contains microbes designed to produce proteins in space.